Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/16283Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Arulananda, Surein | - |
| dc.contributor.author | John, Thomas | - |
| dc.date | 2016-09-01 | - |
| dc.date.accessioned | 2016-09-21T01:21:48Z | - |
| dc.date.available | 2016-09-21T01:21:48Z | - |
| dc.date.issued | 2016-09-01 | - |
| dc.identifier.citation | JAMA Oncology 2016; online first: 1 September | en_US |
| dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/16283 | - |
| dc.description | Invited commentary | en_US |
| dc.title | The ADAM trial: visiting the road less traveled | en_US |
| dc.type | Journal Article | en_US |
| dc.identifier.journaltitle | JAMA Oncology | en_US |
| dc.identifier.affiliation | Austin Health, Heidelberg, Victoria, Australia | en_US |
| dc.identifier.affiliation | Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia | en_US |
| dc.identifier.pubmeduri | https://pubmed.ncbi.nlm.nih.gov/27584157 | en_US |
| dc.identifier.doi | 10.1001/jamaoncol.2016.2854 | en_US |
| dc.type.content | Text | en_US |
| dc.type.austin | Journal Article | en_US |
| local.name.researcher | John, Thomas | |
| item.fulltext | No Fulltext | - |
| item.openairetype | Journal Article | - |
| item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
| item.grantfulltext | none | - |
| item.cerifentitytype | Publications | - |
| crisitem.author.dept | Olivia Newton-John Cancer Research Institute | - |
| crisitem.author.dept | Medical Oncology | - |
| crisitem.author.dept | Olivia Newton-John Cancer Wellness and Research Centre | - |
| Appears in Collections: | Journal articles | |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.